All
Kaléo to Reintroduce AUVI-Q to US Market
October 26th 2016Kaléo announced on Oct. 26, 2016 that the company will reintroduce the AUVI-Q (epinephrine injection) to the United States market during the first half of 2017. AUVI-Q is a prescription epinephrine autoinjector used to treat anaphylaxis. The autoinjector includes an automatically retractable needle and a voice prompt system that guides the user through delivery.
Natoli Hosts Technical Training Course on Tablet Manufacturing
October 19th 2016Natoli Engineering is hosting a technical training course on the basics of tablet manufacturing and troubleshooting. Natoli is holding the three-day course for professionals in the pharmaceutical, tablet compression, veterinary, nutritional, confectionary, and industrial markets. The dates for the 2017 course are: